杨文国, 谭鹏, 奉馨冰. 超分割放疗联合化疗治疗局部晚期鼻咽癌的疗效观察[J]. 中国肿瘤临床, 2006, 33(18): 1051-1054.
引用本文: 杨文国, 谭鹏, 奉馨冰. 超分割放疗联合化疗治疗局部晚期鼻咽癌的疗效观察[J]. 中国肿瘤临床, 2006, 33(18): 1051-1054.
Yang Wenguo, Tan Peng, Feng Xinbing. The Observation of Combined Therapy with Hyperfractionation and Chemotherapy on Local Advanced Nasopharyngeal Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 33(18): 1051-1054.
Citation: Yang Wenguo, Tan Peng, Feng Xinbing. The Observation of Combined Therapy with Hyperfractionation and Chemotherapy on Local Advanced Nasopharyngeal Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 33(18): 1051-1054.

超分割放疗联合化疗治疗局部晚期鼻咽癌的疗效观察

The Observation of Combined Therapy with Hyperfractionation and Chemotherapy on Local Advanced Nasopharyngeal Carcinoma

  • 摘要: 目的 :观察超分割放疗同时化疗对局部晚期鼻咽癌近期、远期疗效的影响及毒性反应。 方法 :69例Ⅲ、Ⅳa期初治NPC患者随机分为超分割放疗+化疗组;超分割放疗组;常规放疗组。鼻咽原发灶采用60Co外照射,颈部淋巴结引流区采用60Co前切线照射加深部X线垂直照射。 结果 :放疗结束后3个月时鼻咽原发灶消退率分别为80.0%、68.4%和55.0%,各组间无统计学差异(P<0.05);颈部淋巴结消退率分别为82.4%、52.9%和50.0%,其中化疗组明显高于常规放疗组(P<0.05),其余各组间均无统计学差异(P<0.05)。3年生存率(70.0%,73.7%,65.0%)。 结论 :超分割放疗同时联合化疗可提高近期颈部淋巴结的完全消退率,但未能提高长期生存率、改善局部控制率和减少远地转移率,其毒性反应可耐受。

     

    Abstract: Objective :To observe the short-term and long-term curative effect and adverse reaction of the combined therapy with hyperfractionation and chemotherapy on local advanced nasopharyngeal carcinoma(NPC). Methods :A total of 69 patients with stage Ⅲ and Ⅳa NPC receiving the initial treatment were randomized into the group of hyperfractionation plus chemotherapy,group of hyperfractionation and the group of conventional radiotherapy.The 60Co external irradiation was employed for treatment of the NPC and the 60Co anterior tangential irradiation plus vertical X-ray irradiation on deep part was used in drainage area of the lymph node of neck. Results :The regression rate of NPC focus 3 months after radiotherapy was 80.0%,68.4% and 55.0%,respectively and there was no statistical difference between the group(P<0.05).The regression rate of the lymph node of neck was 82.4%,52.9% and 50.0%,respectively,among which the regression rate in chemotherapy group was obviously higher than that in the conventional radiotherapy group(P<0.05).There was no significant difference between the groups(P<0.05).The 3-year survivals were 70.0%,73.7% and 65.0%. Conclusion :The combined therapy with hyperfractionation and chemotherapy on local advanced NPC can improve the short-term complete regression of the lymph node of neck,but failed to enhance the long-term survival rate and local controls,as well as to reduce distant metastasis rate.The toxic reaction is tolerant.

     

/

返回文章
返回